TrialBMC cancer2005

Randomized phase II--study evaluating EGFR targeting therapy with cetuximab in combination with radiotherapy and chemotherapy for patients with locally advanced pancreatic cancer--PARC: study protocol [ISRCTN56652283].

R Krempien et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.